Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.
about
Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.Effect of dietary omega-3 fatty acid supplementation on frailty-related phenotypes in older adults: a systematic review and meta-analysis protocol.Ethanol and unsaturated dietary fat induce unique patterns of hepatic ω-6 and ω-3 PUFA oxylipins in a mouse model of alcoholic liver disease
P2860
Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@en
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@nl
type
label
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@en
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@nl
prefLabel
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@en
Hydroxyeicosapentaenoic acids ...... alcoholic fatty liver disease.
@nl
P2093
P2860
P356
P1476
Hydroxyeicosapentaenoic acids ...... nalcoholic fatty liver disease
@en
P2093
Chunjiong Wang
Hongfeng Jiang
Jinlong He
Xuejiao Zhang
P2860
P304
P356
10.1111/BPH.13844
P407
P50
P577
2017-06-09T00:00:00Z